ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Thomas Hughes leaves Zafgen to take CEO role at Navitor
August 06, 2018Thomas Hughes, Ph.D., has left Zafgen to become CEO at mTORC1 startup Navitor Pharmaceuticals. Hughes helmed Zafgen through a turbulent time in which it abandoned its lead candidate after patients died in a phase 3 study. -
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138
June 27, 2018Navitor Pharmaceuticals announced the initiation of a Phase 1 clinical study with its lead pipeline candidate, NV-5138, for treatment-resistant depression (TRD).
Pharma Sources Insight January 2025
